Effects of interleukin-1, -2, -4, -6, interferon-gamma and granulocyte/macrophage colony stimulating factor on human vascular endothelial cells.

[1]  D. Gemsa,et al.  Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2. , 1989, Journal of immunology.

[2]  B. Lokeshwar,et al.  Both granulocyte-macrophage CSF and macrophage CSF control the proliferation and survival of the same subset of alveolar macrophages. , 1989, Journal of immunology.

[3]  A. Mantovani,et al.  IL-1 stimulates IL-6 production in endothelial cells. , 1989, Journal of immunology.

[4]  T. Hirano,et al.  Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. , 1989, Journal of immunology.

[5]  J. Ceuppens,et al.  Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2. , 1988, Journal of immunology.

[6]  P. Hart,et al.  Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity. , 1988, Journal of immunology.

[7]  T. Hirano,et al.  Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells. , 1988, Journal of immunology.

[8]  L. Wahl,et al.  Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor. , 1988, Journal of immunology.

[9]  C. Dinarello,et al.  Biology of interleukin 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  W. Paul.  Interleukin 4/B cell stimulatory factor 1: one lymphokine, many functions 1 , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  J. Sixma,et al.  Interleukin‐l Inhibits the Synthesis of von Willebrand Factor in Endothelial Cells, Which Results in a Decreased Reactivity of Their Matrix toward Platelets , 1987, Arteriosclerosis.

[12]  Y. Saegusa,et al.  Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. , 1987, Journal of immunology.

[13]  F. Booth,et al.  An in vitro model for the study of acute release of von Willebrand factor from human endothelial cells , 1987, British journal of haematology.

[14]  P. Morrissey,et al.  Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. , 1987, Journal of immunology.

[15]  J. Adamson,et al.  Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor. , 1987, Journal of immunology.

[16]  R. Kamen,et al.  The human hematopoietic colony-stimulating factors. , 1987, Science.

[17]  R. Friesel,et al.  Inhibition of endothelial cell proliferation by gamma-interferon , 1987, The Journal of cell biology.

[18]  H. Ijichi,et al.  Modulation of prostacyclin generation in cultured human vascular endothelial cells and the effects of human alpha-natriuretic polypeptide. , 1986, Biochimica et biophysica acta.

[19]  W. Fiers,et al.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. , 1986, Journal of immunology.

[20]  P. Libby,et al.  Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. , 1986, The American journal of pathology.

[21]  L. Chess,et al.  Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 , 1986, The Journal of experimental medicine.

[22]  K. Hajjar,et al.  Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor , 1986, The Journal of experimental medicine.

[23]  A. Mantovani,et al.  Interleukin 1 stimulates platelet activating factor production in cultured human endothelial cells. , 1986, Pharmacological research communications.

[24]  T. Kooistra,et al.  Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells , 1986, The Journal of experimental medicine.

[25]  W. Fiers,et al.  Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. , 1986, The American journal of pathology.

[26]  P. Miossec,et al.  Production of interleukin 1 by human endothelial cells. , 1986, Journal of immunology.

[27]  R. Schleimer,et al.  Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters. , 1986, Journal of immunology.

[28]  D. Haskard,et al.  Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. , 1986, Journal of immunology.

[29]  P. Lipsky,et al.  Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression. , 1985, Journal of immunology.

[30]  C. Yu,et al.  Human gamma interferon increases the binding of T lymphocytes to endothelial cells. , 1985, Clinical and experimental immunology.

[31]  R. Cotran,et al.  Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. , 1985, The Journal of clinical investigation.

[32]  P. Needleman,et al.  Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1. , 1985, Journal of immunology.

[33]  L. Orci,et al.  Human endothelial cell cultures: Phenotypic modulation by leukocyte interleukins , 1985, Journal of cellular physiology.

[34]  J. Harlan.  Leukocyte-endothelial interactions. , 1985, Blood.

[35]  R. Vetto,et al.  The mechanism of antigen presentation by endothelial cells. , 1984, Immunobiology.

[36]  P. Lipsky,et al.  Immunologic function of endothelial cells: guinea pig aortic endothelial cells support mitogen-induced T lymphocyte activation, but do not function as antigen-presenting cells. , 1984, Journal of immunology.

[37]  P. Stastny,et al.  Accessory cell function of human endothelial cells. I. A subpopulation of Ia positive cells is required for antigen presentation. , 1983, Journal of immunology.

[38]  R. Cotran,et al.  Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon , 1983, The Journal of experimental medicine.

[39]  H. Hirschberg.  Presentation of viral antigens by human vascular endothelial cells in vitro. , 1981, Human immunology.

[40]  P. Lipsky,et al.  Human endothelial cell-lymphocyte interaction. Endothelial cells function as accessory cells necessary for mitogen-induced human T lymphocyte activation in vitro. , 1981, The Journal of clinical investigation.

[41]  R. Schwartz,et al.  Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice , 1980, The Journal of experimental medicine.

[42]  T. N. Finley,et al.  Proliferative Capacity of Human Alveolar Macrophage , 1974, Nature.

[43]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[44]  J. Snick,et al.  Interleukin-6: an overview. , 1990, Annual review of immunology.

[45]  M. Haine,et al.  Van Damme A. , 1986 .